Zhejiang Huahai Pharmaceutical Co Ltd (600521) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH135710D
- Pages: 31
- September 2018
- Total Views:1170
- Region : Asia
- GlobalData
- Equity Research Report
Details
Summary
Zhejiang Huahai Pharmaceutical Co Ltd (Huahai Pharmaceuticals) is a pharmaceutical company that carries out the research, production and sale of formulations, active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The company also offers technology services. It provides pharmaceutical products in cardiovascular, central nervous system (CNS), metabolic disorders, infectious disease, women's health and ophthalmology therapy areas. Huahai Pharmaceuticals has established domestic marketing network in compliance with GSP standards, with formulations covering several provinces and municipals of China. Operating through subsidiaries in the US and China, the company distributes its products to several countries worldwide. Huahai Pharmaceuticals is headquartered in Zhejiang, China.
Zhejiang Huahai Pharmaceutical Co Ltd (600521)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Zhejiang Huahai Enters into Co-Development Agreement with Tianjin Pharma 11
Zhejiang Huahai Pharma Enters Into Co-Development Agreement With Institute of Pharmacology and Toxicology Academy of Military Medical Sciences 12
Zhejiang Huahai Pharma Enters Into Co-Development Agreement With Institute of Pharmacology and Toxicology Academy of Military Medical Sciences For Central Nervous System Drugs 13
Zhejiang Huahai Pharma Amends its Co-Development Agreement with Oncobiologics 14
Breckenridge Pharma Enters Into Co-Marketing Agreement With Zhejiang Huahai Pharma For Nevirapine 16
Licensing Agreements 17
Zhejiang Huahai Pharma Enters into Licensing Agreement with Eutilex 17
Huabobio Enters Into Licensing Agreement With ChemPartner 18
Equity Offering 19
Zhejiang Huahai Pharma Raises USD49 Million in Private Placement of Shares for 19
Zhejiang Huahai Pharma Announces Public Offering Of Shares For USD 125 Million 20
Zhejiang Huahai Pharma Announces Public Offering Of Shares For USD 127 Million 21
Debt Offering 22
Zhejiang Huahai Pharma Plans to Raise up to USD274.6 Million in Public Offering of Convertible Bonds Due 2023 22
Zhejiang Huahai Pharma Completes First Tranche Of Private Placement Of Notes For USD 48 Million 23
Zhejiang Huahai Pharma Completes Private Placement Of Notes Due 2013 For USD 32 Million 24
Acquisition 25
Zhejiang Huahai Pharma to Acquire 18.75% Stake in Eutilex for USD30 Million 25
Zhejiang Huahai Pharmaceutical Co Ltd-Key Competitors 26
Zhejiang Huahai Pharmaceutical Co Ltd-Key Employees 27
Zhejiang Huahai Pharmaceutical Co Ltd-Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Legal and Regulatory 30
Sep 13, 2018: Update on review of valsartan medicines 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31
List Of Figure
List of Figures
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List Of Table
List of Tables
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Huahai Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zhejiang Huahai Enters into Co-Development Agreement with Tianjin Pharma 11
Zhejiang Huahai Pharma Enters Into Co-Development Agreement With Institute of Pharmacology and Toxicology Academy of Military Medical Sciences 12
Zhejiang Huahai Pharma Enters Into Co-Development Agreement With Institute of Pharmacology and Toxicology Academy of Military Medical Sciences For Central Nervous System Drugs 13
Zhejiang Huahai Pharma Amends its Co-Development Agreement with Oncobiologics 14
Breckenridge Pharma Enters Into Co-Marketing Agreement With Zhejiang Huahai Pharma For Nevirapine 16
Zhejiang Huahai Pharma Enters into Licensing Agreement with Eutilex 17
Huabobio Enters Into Licensing Agreement With ChemPartner 18
Zhejiang Huahai Pharma Raises USD49 Million in Private Placement of Shares for 19
Zhejiang Huahai Pharma Announces Public Offering Of Shares For USD 125 Million 20
Zhejiang Huahai Pharma Announces Public Offering Of Shares For USD 127 Million 21
Zhejiang Huahai Pharma Plans to Raise up to USD274.6 Million in Public Offering of Convertible Bonds Due 2023 22
Zhejiang Huahai Pharma Completes First Tranche Of Private Placement Of Notes For USD 48 Million 23
Zhejiang Huahai Pharma Completes Private Placement Of Notes Due 2013 For USD 32 Million 24
Zhejiang Huahai Pharma to Acquire 18.75% Stake in Eutilex for USD30 Million 25
Zhejiang Huahai Pharmaceutical Co Ltd, Key Competitors 26
Zhejiang Huahai Pharmaceutical Co Ltd, Key Employees 27
Zhejiang Huahai Pharmaceutical Co Ltd, Subsidiaries 28
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Zhejiang Huahai Pharmaceutical Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Zhejiang Huahai Pharmaceutical Co Ltd (Huahai Pharmaceuticals) is a pharmaceutical company that carries out the research, production and sale of formulations, active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The company also offers technology services. It provides pharmaceutical products in cardiovascular, central nervous system (CNS), metabolic disorders, infectious disease, women's health and ophthalmology therapy areas. Huahai Pharmaceuticals has established domestic marketing network in compliance with GSP standards, with formulations covering several provinces and municipals of China. Operating through subsidiaries in the US and China, the company distributes its products to several countries worldwide. Huahai Pharmaceuticals is headquartered in Zhejiang, China.
Zhejiang Huahai Pharmaceutical Co Ltd (600521)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Zhejiang Huahai Enters into Co-Development Agreement with Tianjin Pharma 11
Zhejiang Huahai Pharma Enters Into Co-Development Agreement With Institute of Pharmacology and Toxicology Academy of Military Medical Sciences 12
Zhejiang Huahai Pharma Enters Into Co-Development Agreement With Institute of Pharmacology and Toxicology Academy of Military Medical Sciences For Central Nervous System Drugs 13
Zhejiang Huahai Pharma Amends its Co-Development Agreement with Oncobiologics 14
Breckenridge Pharma Enters Into Co-Marketing Agreement With Zhejiang Huahai Pharma For Nevirapine 16
Licensing Agreements 17
Zhejiang Huahai Pharma Enters into Licensing Agreement with Eutilex 17
Huabobio Enters Into Licensing Agreement With ChemPartner 18
Equity Offering 19
Zhejiang Huahai Pharma Raises USD49 Million in Private Placement of Shares for 19
Zhejiang Huahai Pharma Announces Public Offering Of Shares For USD 125 Million 20
Zhejiang Huahai Pharma Announces Public Offering Of Shares For USD 127 Million 21
Debt Offering 22
Zhejiang Huahai Pharma Plans to Raise up to USD274.6 Million in Public Offering of Convertible Bonds Due 2023 22
Zhejiang Huahai Pharma Completes First Tranche Of Private Placement Of Notes For USD 48 Million 23
Zhejiang Huahai Pharma Completes Private Placement Of Notes Due 2013 For USD 32 Million 24
Acquisition 25
Zhejiang Huahai Pharma to Acquire 18.75% Stake in Eutilex for USD30 Million 25
Zhejiang Huahai Pharmaceutical Co Ltd-Key Competitors 26
Zhejiang Huahai Pharmaceutical Co Ltd-Key Employees 27
Zhejiang Huahai Pharmaceutical Co Ltd-Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Legal and Regulatory 30
Sep 13, 2018: Update on review of valsartan medicines 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31
List Of Figure
List of Figures
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List Of Table
List of Tables
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Huahai Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Zhejiang Huahai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zhejiang Huahai Enters into Co-Development Agreement with Tianjin Pharma 11
Zhejiang Huahai Pharma Enters Into Co-Development Agreement With Institute of Pharmacology and Toxicology Academy of Military Medical Sciences 12
Zhejiang Huahai Pharma Enters Into Co-Development Agreement With Institute of Pharmacology and Toxicology Academy of Military Medical Sciences For Central Nervous System Drugs 13
Zhejiang Huahai Pharma Amends its Co-Development Agreement with Oncobiologics 14
Breckenridge Pharma Enters Into Co-Marketing Agreement With Zhejiang Huahai Pharma For Nevirapine 16
Zhejiang Huahai Pharma Enters into Licensing Agreement with Eutilex 17
Huabobio Enters Into Licensing Agreement With ChemPartner 18
Zhejiang Huahai Pharma Raises USD49 Million in Private Placement of Shares for 19
Zhejiang Huahai Pharma Announces Public Offering Of Shares For USD 125 Million 20
Zhejiang Huahai Pharma Announces Public Offering Of Shares For USD 127 Million 21
Zhejiang Huahai Pharma Plans to Raise up to USD274.6 Million in Public Offering of Convertible Bonds Due 2023 22
Zhejiang Huahai Pharma Completes First Tranche Of Private Placement Of Notes For USD 48 Million 23
Zhejiang Huahai Pharma Completes Private Placement Of Notes Due 2013 For USD 32 Million 24
Zhejiang Huahai Pharma to Acquire 18.75% Stake in Eutilex for USD30 Million 25
Zhejiang Huahai Pharmaceutical Co Ltd, Key Competitors 26
Zhejiang Huahai Pharmaceutical Co Ltd, Key Employees 27
Zhejiang Huahai Pharmaceutical Co Ltd, Subsidiaries 28
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Zhejiang Huahai Pharmaceutical Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 130 | 
December 2020
Page 130 | December 2020
Page 131 | November 2020
Page 95 | November 2020
Page 96 | August 2020